MARKET

COLL

COLL

Collegium Pharmaceutical Inc
NASDAQ
26.18
+0.58
+2.27%
After Hours: 26.18 0 0.00% 16:20 12/04 EST
OPEN
25.60
PREV CLOSE
25.60
HIGH
26.28
LOW
25.21
VOLUME
338.50K
TURNOVER
0
52 WEEK HIGH
30.22
52 WEEK LOW
20.83
MARKET CAP
853.75M
P/E (TTM)
174.30
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at COLL last week (1127-1201)?
Weekly Report · 16h ago
Collegium Pharmaceutical Inc: Statement of changes in beneficial ownership of securities
Press release · 5d ago
Collegium Pharmaceutical Inc: Report of proposed sale of securities
Press release · 11/27 22:03
Weekly Report: what happened at COLL last week (1120-1124)?
Weekly Report · 11/27 09:27
Weekly Report: what happened at COLL last week (1113-1117)?
Weekly Report · 11/20 09:27
Weekly Report: what happened at COLL last week (1106-1110)?
Weekly Report · 11/13 09:26
Here's Why Collegium Pharmaceutical (NASDAQ:COLL) Can Manage Its Debt Responsibly
Collegium pharmaceutical, inc. (nasdaq:coll) makes use of debt. Debt is often involved when a business collapses. Collegium pharmaceutical had us$711.0m of debt, at september 2023. Debt can be an important tool to help businesses grow.
Simply Wall St · 11/12 13:29
Validea Joel Greenblatt Strategy Daily Upgrade Report - 11/10/2023
NASDAQ · 11/10 10:08
More
About COLL
Collegium Pharmaceutical, Inc. is a diversified specialty pharmaceutical company. The Company commercializes its pain portfolio, consisting of Xtampza extended-release (ER), Nucynta Products, Belbuca, and Symproic in the United States. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of oxycodone. Xtampza ER is for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The Nucynta Products are extended-release (ER) and immediate-release (IR) formulations of tapentadol. Nucynta ER is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. Nucynta IR is indicated for the management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate in adults. Belbuca is a buccal film that contains buprenorphine, a partial opioid agonist. Symproic is an oral formulation of naldemedine.

Webull offers Collegium Pharmaceutical Inc stock information, including NASDAQ: COLL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, COLL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading COLL stock methods without spending real money on the virtual paper trading platform.